Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Molly S.C. Li"'
Autor:
Alvin H.K. Cheung, MBBS, PhD, Zeta Mui, MPhil, Walter W. Yeung, PhD, Chit Chow, PhD, Mandy F. Yu, BSc, Olivia H. Chen, MD, PhD, Kit-Yee Wong, MPhil, Fuda Xie, MPhil, Yat Ming Lau, MBBS, Alfred S-L. Cheng, PhD, Wei Kang, PhD, Ka-Fai To, MBChB, Tony S. Mok, MD, Molly S.C. Li, MBBS
Publikováno v:
JTO Clinical and Research Reports, Vol 6, Iss 1, Pp 100754- (2025)
Introduction: The germline human leukocyte antigen (HLA) status has been found to be associated with immunotherapy outcomes in patients with NSCLC, but its correlation to immunotherapy-induced pneumonitis and prognostic impact in the Asian population
Externí odkaz:
https://doaj.org/article/059884a272f345c18d1c55e8ba3a0eda
Autor:
Molly S.C. Li, M.B.B.S., Kirsty W.C. Lee, MBChB, Kevin K.S. Mok, MBChB, Herbert H.F. Loong, M.B.B.S., K.C. Lam, MBChB, Florence S.T. Mok, M.B.B.S., Landon L. Chan, MBChB, Y.M. Lau, M.B.B.S., K.P. Chan, MBChB, Joyce T.Y. Ng, MBChB, Wesley K.Y. Wong, M.B.B.S., Benjamin H.W. Lam, M.B.B.S., Allen C.C. Chen, BM, Matthew M.P. Lee, MBChB, Olivia H. Chen, MD, PhD, Tony S.K. Mok, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100648- (2024)
Introduction: Interstitial lung disease (ILD) is the most frequent cause of drug-related mortality from EGFR tyrosine kinase inhibitors (TKIs). Yet, for patients with symptomatic osimertinib-induced ILD, the risk of recurrent ILD associated with EGFR
Externí odkaz:
https://doaj.org/article/3e7352949ccd4e5d8d2933a594642014
Publikováno v:
The Journal of Liquid Biopsy, Vol 3, Iss , Pp 100131- (2024)
Molecular profiling is essential for treatment of patients with advanced non-small cell lung cancer. Extensive evidence supports the clinical application of liquid biopsy in molecular profiling and thus has been incorporated into multiple internation
Externí odkaz:
https://doaj.org/article/ea7cb5082ad1433a842e674d1fbbba18
Publikováno v:
Journal of Thoracic Oncology. 15:1100-1102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15aab6c54e3a926987eac3f80a80a862
https://doi.org/10.1016/j.jtho.2020.03.026
https://doi.org/10.1016/j.jtho.2020.03.026
Publikováno v:
Cancer Weekly; 12/10/2024, p1414-1414, 1p
Publikováno v:
Respiratory Therapeutics Week; 4/19/2024, p2101-2101, 1p